Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > BTD and pre-BTD overview

<< Previous

Bullboard Posts

Next >>

Comment by FGPstockon Oct 10, 2023 10:29am

217 Views

Post# 35676931

RE:RE:BTD and pre-BTD overview

yea, seems like they screwed up again.... in their nov 2022 nr saying they were applying for btd in q4 2022, there was no mention of any pre-btd process and we all started the 60 day clock. Many said Dr Vera left Tlt because she already delivered on the btd and accomplished her task, but it seems she may have been frustrated at tlt

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter